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Abstract
Background: The aim was to analyse participation trajectories in organised breast and cervical cancer screening
programmes and the association between socioeconomic variables and participation.
Methods: A pooled, cross-sectional, time series analysis was used to evaluate secondary data from 17 European
countries in 2004–2014.
Results: The results show that the mammographic screening trend decreases after an initial increase (coefficient for the
linear term = 0.40; p = 0.210; 95% CI = − 0.25, 1.06; coefficient for the quadratic term = − 0.07; p = 0.027; 95% CI =− 0.14, −
0.01), while the cervical screening trend is essentially stable (coefficient for the linear term = 0.39, p = 0.312, 95% CI = − 0.
42, 1.20; coefficient for the quadratic term = 0.02, p = 0.689, 95% CI = − 0.07, 0.10). There is a significant difference among
the country-specific slopes for breast and cervical cancer screening (SD = 16.7, p < 0.001; SD = 14.4, p < 0.001, respectively).
No association is found between participation rate and educational level, income, type of employment, unemployment
and preventive expenditure. However, participation in cervical cancer screening is significantly associated with a higher
proportion of younger women (≤ 49 years) and a higher Gini index (that is, higher income inequality).
Conclusions: In conclusion three messages: organized cancer screening programmes may reduce the socioeconomic
inequalities in younger people’s use of preventive services over time; socioeconomic variables are not related to
participation rates; these rates do not reach a level of stability in several countries. Therefore, without effective recruitment
strategies and tailored organizations, screening participation may not achieve additional gains.
Keywords: Breast cancer, Cervical cancer, Healthcare, Organized screening, Socioeconomic inequalities, Socioeconomic
variables, Trend
Background
Screening for breast and cervical cancer is strongly re-
lated with a reduction in cancer mortality [1, 2].
Screening strategies differ between countries. Some
countries have organized screening that systematically
tests all women in the defined target group, either on a
national or regional level [3].
Opportunistic screenings, in which the women’s par-
ticipation is a result of a recommendation made by a
healthcare practitioner or of their own choice, are
adopted by other countries [4].
An assessment of these screening programmes shows
that the coverage of the target population and positive
response to screening are higher in population-based
programmes than in opportunistic screening [5]. The as-
sessment of these screening programmes also shows that
organized screening programmes for breast and cervical
cancer based on an active recruitment strategy are better
than opportunistic screenings as far as increasing par-
ticipation rates are concerned [6, 7].
Because of their increased population coverage,
follow-up and quality control, population-based pro-
grammes effectively reduce mortality and control the
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inappropriate use of screening tests [8–11], whereas op-
portunistic screening is strongly criticized for using
community resources without any demonstrable effect
on cancer rates [12].
Some studies highlight the fact that social and economic
factors correlate with use of cancer screening, and socio-
economic inequity in cancer screening is dramatically re-
duced in countries with organized screening programmes
compared with countries without them [5, 13, 14].
Thus, implementing organised screening programmes
has been recommended by the European Community [15],
and many member states have done so. To date, most
European countries have developed population-based
screening programmes for both breast and cervical cancers,
but they differ in terms of organisational characteristics, im-
plementation stage, and coverage [16–18].
To our knowledge, there is no study that focuses on
this type of data from several EU countries to analyse
participation rates in organised breast and cervical can-
cer screening programmes.
The aims of this study are as follows: i) to analyse par-
ticipation rates in organised breast and cervical cancer
screening programmes in 17 European countries; ii) to
describe the annual variations in screening attendance
rate during 2004–2014 and to determine the trend over
time; and iii) to systematically analyse the association be-
tween socioeconomic variables and participation rates.
Methods
We conducted a pooled, cross-sectional, time series ana-
lysis of 17 European countries over the period 2004–
2014. The countries included in the study were: Belgium,
Czech Republic, Denmark, Estonia, Finland, France,
Germany, Iceland, Ireland, Italy, Luxembourg,
Netherlands, Norway, Slovakia, Slovenia, Sweden, and
United Kingdom. These countries and years were chosen
based on data availability.
We obtained official, secondary data from the
Organization for Economic Co-operation and Develop-
ment (OECD), Eurostat and Global Economic Monitor.
The indicators considered in the present study are listed
in Table 1, which includes the definition and source of
each item. All indicators were selected for females ex-
cept the economic indicators (i.e. indicators: 3; 4; 5a;
5b), for which sex stratification was not available.
Statistical analyses
Statistical methods used in this study were drawn from
previously published works [19, 20].
First, a time trend analysis was performed by using a
fixed-effects polynomial regression on the annual partici-
pation rates in breast and cervical cancer screening pro-
grammes. Second, a pooled time-series cross-section
analysis was performed to assess the association between
the screening participation rates (indicators 1a and 1b, i.e.,
dependent variables) and a set of independent variables
(indicators 2a to 8) over the 11-year study period. We
chose to fit a linear model because the dependent vari-
ables were confirmed to be normally distributed by per-
forming the Shapiro-Wilk and Shapiro-Francia tests [21].
To avoid model overfitting, indicators 2c to 2 l were
halved by collapsing age groups, while secondary and ter-
tiary education levels (6f to 6q) were merged because they
yielded similar results. Additionally, no results were re-
ported for indicators 2a and 2b, 2 m, and 6a to 6e because
they make 100 when added to the indicators 2c to 2 l, 2n
to 2p, and 6f to 6q, respectively. Due to potential
over-fitting and multi-collinearity, we separately examined
the relationship between all the remaining dependent and
independent variables, resulting in 21 distinct fixed-effects
models. The proportion of missing observations per
model ranged from 0% (educational attainment) to ap-
proximately 25% (unemployment/self-employment), and
listwise deletion was used because all data appeared to be
missing at random (data not shown).
All data were analysed using the Stata software package,
version 13 (StataCorp. 2013, Stata Statistical Software: Re-
lease 13; StataCorp LP, College Station, TX, USA). For all
analyses, the significance level was set at p < 0.05.
Results
Screening attendance rates
For breast screening, all countries have had national or
regional screening programmes since 2004, except for
Denmark and Slovenia, whose programmes began as
pilot programmes in 2009 and 2008, respectively.
There is great variability between the countries: in
Slovakia, participation in mammographic screening does
not reach 30%, while in Finland the percentage is always
higher than 80%. Countries such as Belgium, the Czech
Republic, Estonia, France, Germany, Iceland, Italy and
Luxembourg do not reach the 70% participation thresh-
old outlined in the European Guidelines (Fig. 1).
Three countries have no cervical screening pro-
grammes (France, Germany and Luxembourg). Other
countries have screening programmes since 2004, except
for Estonia (since 2008) and Ireland with a nationwide
programme since 2007. There is high variability, and no
programme reaches the 85% threshold defined in the
European guidelines. The largest attendance rates are
registered in Sweden, the UK and Norway (Fig. 1).
Annual trends in screening attendance rates
The linear trend of participation in mammographic
screening is not significant (coefficient for the linear
term = 0.40; p = 0.210; 95% CI = − 0.25, 1.06) but is sig-
nificantly “curved” (coefficient for the quadratic term =
− 0.07; p = 0.027; 95% CI = − 0.14, − 0.01). When the
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Table 1 Indicators, definitions and data sources
# Indicator Definition Source
1a. Breast cancer screening,
programme data
Females aged 50–69
screened (%)
OECD Health Statistics 2017
1b. Cervical cancer screening,
programme data
Females aged 20–69
screened (%)
OECD Health Statistics 2017
2a; 2b; 2c; 2d; 2e; 2f; 2 g; 2 h; 2i; 2 l Demographic structure Persons, Female, ten age
classes (25–29; 30–34; 35–39,
40–44; 45–49;50–54;55–59;60–
64;65–69 years) over 20–69 (%)
OECD Health Statistics 2017
2 m; 2n; 2o; 2p Demographic structure Persons, Female, four age classes
(50–54;55–59;60–64;
65–69 years), over 50–69 (%)
OECD Health Statistics 2017
3. Income of households Euro per inhabitant, disposable
income. Household income
includes every form of income
(e.g., salaries and wages,
retirement income, near
cash government transfers
like food stamps, and
investment gains) available
for spending and
saving after income taxes.
EUROSTAT 2017
4. Gini - index of income equality The Gini coefficient is a
measure of income distribution
and is used to determine
income inequality in a population.
It ranges from 0 to 100%,
with 0% representing perfect
equality (i.e., every resident
has the same income), and
100% representing perfect
inequality (i.e., one resident
earns all the income). The
index of income equality
refers to disposable income,
post taxes and transfers,
in a working age
population aged 18–65.
OECD Health Statistics 2017
5a. Preventive Care All
Financing Schemes
Per capita, constant prices,
constant PPPs, OECD
base year – US Dollar 2010.
Financing Schemes identify
the main types of financing
arrangements through which
health services are paid for
and obtained by people
and include the following: i)
Voluntary health insurance
under which the access to
health services is at the
discretion of private actors
through paid premiums; ii)
Out-of-pocket payments under
which the access to health
services is at the discretion
of private actors by a direct
payment for services from the
household primary income
or savings; iii) Government
healthcare financing schemes
that involve financing arrangements
to ensure access to all
citizens/residents, or for a
specific group of the population
(e.g., the poor) defined by
law/government regulation
OECD Health Statistics 2017
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coefficient for the linear term is near zero and the coeffi-
cient for a quadratic term is negative and significant, it
means that the time trend is concave (apex at the top)
and that the values at the beginning and the end of the
study period are similar. As confirmed in Fig. 2, which
illustrates the expected participation rates derived from
the fixed-effects polynomial model, there is a slight de-
crease in participation in breast cancer screening after
an initial slight increase.
Table 2 shows the average annual rates of change in
percentages of women subjected to breast cancer screen-
ing in European countries during the analysed period.
The trend of the individual countries is discordant and it
seems to be unconnected to the geographic area: 5 na-
tions (Czech Republic, Denmark, Estonia, France and
Slovakia) experienced a significant increase in screening
participation, while 3 countries (Finland, Iceland and
Netherland) had a significant decline in participation
rates; all this countries belong to different geographic
areas. The regression model shows that there is a signifi-
cant difference among the country-specific slopes for
breast cancer screening (standard deviation [SD] = 16.7,
p < 0.001).
For uterine cervix screening programmes, neither the
linear nor the quadratic terms are significant (coefficient
for the linear term = 0.39, p = 0.312, 95% CI = − 0.42,
1.20; coefficient for the quadratic term = 0.02, p = 0.689,
95% CI = − 0.07, 0.10). Participation is essentially stable
until the end of the decade (Fig. 2).
Table 2 shows the average annual rates of change in
percentages of women subjected to cervical cancer
screening in European countries during the analysed
period. The trend of the individual countries is again
discordant and again seems to be unconnected to the
geographic area: 5 nations (Czech Republic, Ireland,
Italy, Slovakia and Sweden) experienced a significant in-
crease in screening participation, while 4 countries
(Belgium, Netherland, Norway and UK) had a significant
decline in participation rates. The regression model
shows that there is a significant difference among the
country-specific slopes for cervical cancer screening as
well (SD = 14.4, p < 0.001).
Table 1 Indicators, definitions and data sources (Continued)
# Indicator Definition Source
through domestic revenues
of government (primarily taxes); iv)
Compulsory health insurance that
involves a financing arrangement
to ensure access to healthcare
for specific population groups
through mandatory participation
and eligibility based on the
payment of health insurance
contributions by or on behalf
of the individuals concerned.
5b. Preventive Care Government
schemes and compulsory
contributory health
care financing schemes
Per capita, constant prices,
constant PPPs, OECD
base year - US Dollar 2010
OECD Health Statistics 2017
6a; 6b; 6c; 6d; 6e Educational attainment level Female, five age classes
(20–24; 25–34; 35–44, 45–54;
55–64 years), Less than
primary, primary and lower
secondary education (levels 0–2) (%)
EUROSTAT 2017
6f; 6 g; 6 h; 6i; 6 l Educational attainment level Female, five age classes
(20–24; 25–34; 35–44, 45–54;
55–64 years), Upper secondary
and post-secondary non-tertiary
education (levels 3 and 4) (%)
EUROSTAT 2017
6 m; 6n; 6o; 6p; 6q Educational attainment level Female, five age classes
(20–24; 25–34; 35–44, 45–54;
55–64 years), Tertiary
education (levels 5–8) (%)
EUROSTAT 2017
7 Unemployment Female (% of female labour force)
(modelled International
Labour Organization-ILO estimate)
GLOBAL ECONOMIC MONITOR 2017
8 Self-employed Female (% of female employment) GLOBAL ECONOMIC MONITOR 2017
Abbreviations: OECD, Organization for Economic Co-operation and Development
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Fig. 2 Estimates from the fixed-effects regression analysis. Overall participation rate (%) in breast cancer and cervical cancer screening in 17 EU
countries from 2004 to 2014
Fig. 1 Participation rates (%) in breast cancer and uterine cervix screening in 17 EU countries from 2004-2014A. A Breast screening data not
available for Sweden. Uterine cervix screening data not available for Ireland between 2007 and 2011. Abbreviations: BEL, Belgium; CZE, Czech
Republic; DNK, Denmark; EST, Estonia; FIN, Finland; FRA, France; DEU, Germany; ISL, Iceland; IRL, Ireland; ITA, Italy; LUX, Luxembourg; NDL,
Netherlands; NOR, Norway; SVK, Slovakia; SVN, Slovenia; SWE, Sweden; GBR, United Kingdom
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Table 2 Participation rates (%) for breast cancer and uterine cervix screening in 17 European countries, 2004–2014
Country Breast cancer screening (pop. Aged 50–69) Cervix cancer screening (pop. Aged 20–69)
First available Last available Average P First available Last available Average P
% (Year) % (Year) ann. Change (Slope) % (Year) % (Year) ann. Change (Slope)
Northern Europe
Denmark 73.7 83.9 1.70 0.006 66.3 64.1 −0.44 0.431
(2008) (2014) (2009) (2014)
Finland 87.4 82.8 −0.46 < 0.001 71.6 70.6 −0.10 0.084
(2004) (2014) (2004) (2014)
Iceland 61.0 60.0 −0.10 0.010 73.0 73.0 0.00 0.142
(2004) (2014) (2004) (2014)
Norway 74.6 74.9 0.03 0.132 80.1 73.5 −0.66 < 0.001
(2004) (2014) (2004) (2014)
Sweden n/a n/a n/a n/a 79.3 81.4 0.21 0.008
(2004) (2014)
Central Europe
Belgium 56.0 60.0 0.67 0.177 60.7 53.7 −0.88 0.006
(2004) (2010) (2004) (2012)
France 38.1 52.5 1.44 0.029 n/a n/a n/a n/a
(2004) (2014)
Germany 57.3 56.3 −0.17 0.845 n/a n/a n/a n/a
(2006) (2012)
Luxembourg 62.2 60.7 −0.15 0.218 n/a n/a n/a n/a
(2004) (2014)
Netherlands 81.9 79.4 −0.25 0.002 66.9 64.6 −0.23 0.006
(2004) (2014) (2004) (2014)
British Isles
Ireland 77.1 76.5 −0.06 0.072 60.9 77.0 5.37 0.019
(2004) (2014) (2011) (2014)
United Kingdom 74.7 75.3 0.06 0.294 80.6 77.5 −0.31 < 0.001
(2004) (2014) (2004) (2014)
Southern Europe
Italy 59.0 57.0 −0.20 0.486 37.7 40.5 0.28 < 0.001
(2004) (2014) (2004) (2014)
Eastern Europe
Czech Republic 25.7 60.8 3.51 < 0.001 36.5 52.2 1.57 < 0.001
(2004) (2014) (2004) (2014)
Estonia 41.0 58.0 1.70 < 0.001 32.0 50.0 2.57 0.186
(2004) (2014) (2007) (2014)
Slovakia 14.8 23.1 0.83 0.002 24.9 47.7 2.28 < 0.001
(2004) (2014) (2004) (2014)
Slovenia 85.1 78.5 −1.65 0.876 67.1 71.3 0.47 0.095
(2010) (2014) (2005) (2014)
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Table 3 Results of the regression analysis
Regressor Breast cancer Cervical cancer
screening Screening
Per 100 Per 100
inhabitants Inhabitants
% Persons, Female, aged 55–59 over 50–69 2.29 –
(1.07)
% Persons, Female, aged 60–64 over 50–69 1.79 –
(0.93)
% Persons, Female, aged 65–69 over 50–69 1.42 –
(1.01)
Time effect 0.87
(0.566)
R2 0.954
Countries 16
Average obs.per country 8.9
% Persons, Female, aged 30–39 over 20–69 – 5.18*
(1.11)
% Persons, Female, aged 40–49 over 20–69 – 3.46*
(1.16)
% Persons, Female, aged 50–59 over 20–69 – 3.29
(2.05)
% Persons, Female, aged 60–69 over 20–69 – 1.9
(1.93)
Time effect 1.77
(0.081)
R2 0.942
Countries 13
Average obs. per country 8.2
Mean income of households (€ in thousands) 1.36 0.61
(0.83) (1.01)
Time effect 0.68 1.1
(0.741) (0.372)
R2 0.95 0.901
Countries 14 13
Average obs. per country 8.4 8.4
Gini index (%) 0.35 1.52*
(0.22) (0.35)
Time effect 1.52 1.36
(0.145) (0.216)
R2 0.943 0.89
Countries 16 14
Average obs. per country 7.5 7.6
Preventive Care All Financing Scheme ($) 0.0 −0.05
(0.03) (0.04)
Time effect 1.7 1.41
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Table 3 Results of the regression analysis (Continued)
Regressor Breast cancer Cervical cancer
screening Screening
Per 100 Per 100
inhabitants Inhabitants
(0.089) (0.185)
R2 0.938 0.891
Countries 16 14
Average obs. per country 8.6 8.9
Preventive Care Government and Compulsory insurance schemes ($) −0.07 − 0.15
(0.05) (0.09)
Time effect 2.37 2.3
(0.014) (0.018)
R2 0.939 0.899
Countries 16 14
Average obs. per country 8.6 8.9
Educational attainment level % Female, 20–24 years, – 0.06
Education levels 3–8 0.15
Time effect 1.65
(0.103)
R2 0.902
Countries 14
Average obs. per country 9.1
Educational attainment level % Female, 25–34 years, – −0.31
Education levels 3–8 (0.45)
Time effect 1.46
(0.165)
R2 0.896
Countries 14
Average obs. per country 9.7
Educational attainment level % Female, 35–44 years, – −0.36
Education levels 3–8 (0.29)
Time effect 1.76
0.076
R2 0.898
Countries 14
Average obs. per country 9.7
Educational attainment level % Female, 45–54 years, −0.19 0.11
Education levels 3–8 (0.27) 0.24
Time effect 1.72 0.61
(0.083) (0.800)
R2 0.942 0.894
Countries 16 14
Average obs. per country 9.7 9.7
Educational attainment level % Female, 55–64 years, −0.56 −0.09
Education levels 3–8 (0.32) 0.26
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Socioeconomic variables and screening attendance rates
Table 3 shows the results of the regression analysis,
which evaluates the impact of demographic, social and
economic factors of the population on screening attend-
ance rates. The only significant results relate to the
demographic structure of the female population and the
distribution of income (GINI index). Specifically, there is
a 5.18% increase in screening participation when the
percentage of women aged 30–39 is 1% higher. In
addition, screening participation increases by 3.46%
when the percentage of women aged 40–49 over those
aged 20–69 years is 1% higher.
Additionally, when the percentage of the Gini coeffi-
cient increases, a 1.52% increase in cervical screening at-
tendance is observed.
Discussion
The aim of this study was to analyse participation rates
in organised breast and cervical cancer screening pro-
grammes in 17 European countries, to describe the an-
nual variations in screening attendance rate during
2004–2014, to determine the trend over time and to sys-
tematically analyse the association between socioeco-
nomic variables and participation rates.
Our results show that the countries that had already
in 2004 crossed the 70% threshold of participation to
breast cancer screening, as prescribed by the guidelines,
continued to experience membership rates above the
threshold even in 2014, while the countries that showed
rates lower than 70% in 2004 or the first year that data
screening were available did not reach the recommended
threshold in 2014. No countries reached the 85% attend-
ance rate in cervical cancer screening.
Inferential statistical analysis provides information on
the trend by showing the annual change in screening at-
tendance rates. All 17 European countries experienced a
“curved” trend in breast cancer screening and an essen-
tially stable trend for uterine cervix screening during the
11-year study period. These results demonstrate that,
despite two Cochrane reviews that found interventions
encouraging breast and cervical cancer screening were
effective in increasing participation, these programmes
do not seem sufficient [6, 7].
The analysed countries contribute to these trends with
different average annual change rates that are uncon-
nected to the geographic area.
Several reasons may justify the different slopes of the
countries. The literature highlights that the reasons
Table 3 Results of the regression analysis (Continued)
Regressor Breast cancer Cervical cancer
screening Screening
Per 100 Per 100
inhabitants Inhabitants
Time effect 4.17 0.82
(< 0.001) (0.610)
R2 0.949 0.894
Countries 16 14
Average obs. per country 9.7 9.7
Unemployment, % of female labour force 0.09 0.3
(0.39) (0.34)
Time effect 0.53 0.99
(0.814) (0.446)
R2 0.863 0.896
Countries 16 14
Average obs. per country 7.2 7.4
Self-employed, % of female employment 0.75 −0.13
(0.94) (0.98)
Time effect 0.48 1.35
(0.850) 0.24
R2 0.963 0.896
Countries 16 14
Average obs. per country 7.2 7.4
Notes: Robust standard errors are given in parentheses under the coefficients, and p-values are given in parentheses under the F-statistics of time effect. The
individual coefficient with an asterisk (*) is significant at the 5% level
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behind the failure or success of cancer screening partici-
pation are two-fold. First, there are determinants on the
supply side [22]. Second, there are obstacles on the de-
mand side because certain sections of the target popula-
tion decline the use of the screening offered [22]. On the
supply side, the specialized literature highlights that the
key components of successful programmes include the
following: a high level of target population coverage,
identification of strategies of attendance, personal invita-
tions for all eligible persons [23, 24] and the availability
of trained personnel and adequate equipment [25, 26].
These components are the basis, for example, of the sig-
nificant growth in cervical screening in Ireland, where a
national screening programme called “Cervical Check”
was introduced. This programme extends screening to
100% of the target population, uses an organized call
and recall system of invitation, has a dedicated smear-
taker training unit that runs training courses for new
providers and includes regular updates for established
smeartakers, and increases the availablity of quality as-
sured services such as laboratory services and colpos-
copy for the screening [27]. These components are also
the basis of the constant high level of breast cancer
screening participation rates in British Isles. Indeed, all
English and Irish women aged between 50 and 70, who
are registered with a General Practitioner, are invited
personally to attend for screening mammography by
their local breast screening unit. Each woman receives a
timed appointment, and if a woman does not attend that
appointment she is sent a second timed appointment.
Similarly, these components play a role in the signifi-
cant reduction in cervical screening participation in
Belgium, where formal cervical cancer screening exists
in only one of the three geographically separated regions
(Flemish), and the invitations are not yet sent to all of
the target population [28, 29].
These components also seem to justify, on the one
hand, the significant growth of participation in breast
screening in some Eastern European countries, such as
in the Czech Republic and Slovakia, and on the other
hand, the achievement of modest coverage that is below
the standard ‘acceptable level’ (70%). In the Czech Re-
public, a personal recruitment system through gynaecol-
ogists and general practitioners was introduced for
breast screening and was reinforced by media cam-
paigns, but it has no established centralized system of
direct invitation. In Slovakia, the screening programme
became strictly invitational in 2004, and it targeted age
groups for screening, being limited at first to 45–59 year
olds and then representing women aged 50–65 years
starting in 2007. However, a widely information to
women and an improvement the availability of a quality
service it still needs to be implemented for raising the
participation rate (national cancer strategy) [30].
Obstacles on the demand side may justify the slopes of
other countries. In particular, France has increased the
participation to a breast screening programme; however,
by the end of the years under consideration in this study,
it did not reach the threshold of 70% as set by the Euro-
pean Union [31]. A suggestion is provided by Ferrat et
al., which states there are several barriers that affect at-
tendance to screening programmes, and one of these is
the perceptions of women with regard to the benefits of
prevention [32]. Italy also noticed an increase in partici-
pation to cervical screening thanks to the initiatives of
the National Health Service [33], even though it did not
reach the threshold defined by the European Union. In
fact, according to the study by Damiani et al., the per-
ception of the low efficacy of cancer screening, the anx-
iety about the results and the fear of cancer continue to
affect participation in screening [34].
According to our results, some socioeconomic vari-
ables, such as level of education, income and type of em-
ployment and unemployment, are not related to the rate
of participation in screening.
Educational level did not seem to affect participation,
but women with higher levels of education had slightly
lower attendance compared with women with the lowest
level of education. One possible reason for this trend
may be that more educated women are more likely to
use private services. Other studies have found no associ-
ation between education and participation [13, 35–37],
somewhat lower participation by women with both the
lowest and highest levels of education [38], or an inverse
correlation between level of education and screening at-
tendance [39].
Employment status may be a good measure of socio-
economic status. Among socioeconomic groups based
on employment status, women who are not currently
employed or who are self-employed are less likely to at-
tend a screening. The latter is in keeping with other
studies [40–43].
Mean household income is not related to the rate of
screening participation. This may be because most Euro-
pean health systems offer free or inexpensive testing, re-
ducing financial barriers to screening; this is in keeping
with previous studies demonstrating that cost has no ef-
fect on participation [44].
No association is found between preventive expend-
iture and screening participation. This suggests that
health systems must focus and improve the organization
of screenings, given the evidence that screening reduces
breast and cervical cancer-related mortality. More im-
portantly, it suggests that health systems need to choose
interventions that are more effective at increasing par-
ticipation rates. The literature shows that some types of
interventions are more effective, specifically among
underserved communities, and highlights that other
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types of interventions do not have sufficient evidence of
effectiveness [45].
The lack of association between the above-cited socio-
economic variables and the rate of screening participa-
tion suggests that screening programme success depends
on other variables such as recruitment strategies and tai-
lored organization. This hypothesis is in keeping with
findings from previous studies that show evidence of the
impact of different strategies on enhancing attendance
within a given programme [7, 26, 46]. A review showed
that the most effective recruitment strategies are those
that act on behavioural change by developing tailored
messages that may break down the barriers holding back
screening participation and consequently support
women’s individual decisions [47]. Additionally,
population-based programmes should involve all health
actors who are in contact with the target population, es-
pecially the primary care physicians. Because primary
care physicians are usually the first medical practitioner
contacted by patients and have more familiarity with
them, they may play a key role in promoting screening
[26]. By acting on these other variables, it may be that
the trend of breast cancer screening, which showed a
slight decrease in participation after an initial slight in-
crease, could be affected.
An important finding in this study is that participation
in cervical screening increased when the relative size of
young populations (30–49 years) increased during the
11-year study period. This is not surprising and is consist-
ent with previous studies demonstrating that advanced
age is associated with decreased screening [14, 48].
Another important and more unexpected result is the
positive impact that the GINI index had on participation
in cervical screening. Our findings show that screening
attendance is greater in societies with younger popula-
tion age structure (i.e. % of women aged 30–49 higher)
and greater income inequality (i.e. GINI index higher).
This result, based on a time series analysis during the
11-year period, suggests that organized screening pro-
grammes may be effective in reducing socioeconomic in-
equalities in screening over time. This suggestion is
supported by a review that concludes that a longer
period of time is needed to see the positive effects of an
organized screening programme [26]. Indeed, according
to the review, there is no evidence to date that an orga-
nized programme may be effective in reducing
socio-economic inequalities in screening attendance [26]
but this evidence arises from studies that are biased be-
cause they assess effectiveness after only a short period
following implementation [26]. It has been postulated in
a previous study [49] that public health interventions
initially increase inequalities for coverage and reduce in-
equalities later; this because people with a high
socio-economic position are more likely to be involved
[49], and the poor only gain greater access to the inter-
ventions later [49].
The main weakness of this study is that the analysis
was conducted at the national level, and the state-wide
distribution was not analysed. An analysis carried out
within the national context may highlight particular
groups of women who fail to attend screenings and, im-
portantly, increase understanding of the factors that in-
fluence a woman’s decision to participate in cervical
screenings.
We analysed the trend using a variety of indicators of
socioeconomic status. This approach is supported by the
specialized literature [50, 51], and we consider it a
strength of our study that we used different indicators.
Some preliminary conclusions can be drawn from this
study. First, it appears that organized cancer screening
programmes may over time reduce the socioeconomic
inequalities found in the utilization of preventive ser-
vices by younger people. Second, socioeconomic vari-
ables are not related to participation rates and, third, all
countries do not reach the European standard level set
at 85% for cervical screening, and most countries do not
reach the 70% level that is acceptable by the standards
for breast screening. Moreover, there is evidence that
the participation rates did not reach a level of stability in
several countries during the 11-year study period.
This suggests that without effective recruitment strat-
egies, which also reduce barriers, and without an
organization focused on the characteristics of the spe-
cific country, screening participation may not achieve
additional gains.
Acknowledgements
Not applicable.
Funding
This research received no specific grant from any funding agency in the
public, commercial or not-for-profit sectors.
Availability of data and materials
The datasets used and/or analysed during the current study are available
from the corresponding author on reasonable request.
Authors’ contributions
MMG and GD formulated the research goals and supervised the research
activity; MMG, GD, JL defined the design of the methodology; MMG and MB
wrote the article; WR, RS and MPF revised the article; JL utilized statistical
techniques to analyse the study data; and MB collected the data and
managed the database. All authors have read and approved the manuscript.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Gianino et al. BMC Public Health         (2018) 18:1236 Page 11 of 13
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Public Health Sciences and Pediatrics, Università di Torino,
Via Santena 5 bis, 10126 Turin, Italy. 2Department of Biomedical and
Neuromotor Sciences, Alma Mater Studiorum - Università di Bologna, Via
Ugo Foscolo 7, 40123 Bologna, Italy. 3Fondazione Policlinico Universitario
‘Agostino Gemelli’ IRCSS, Largo Agostino Gemelli 8, 00168 Roma, Italy.
4Istituto di Sanità Pubblica, Università Cattolica del Sacro Cuore, Largo
Francesco Vito 1, 00168 Roma, Italy.
Received: 25 June 2018 Accepted: 26 October 2018
References
1. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of
screening mammography: a meta-analysis. JAMA. 1995;273:149–54.
2. Peirson L, Fitzpatrick-Lewis D, Ciliska D, Warren R. Screening for cervical
cancer: a systematic review and meta-analysis. Syst Rev. 2013;2:35.
3. Ponti A, Anttila A, Ronco G, Senore C, Basu P, Segnan N, et al. Cancer
screening in the European Union - report on the implementation of the
council recommendation on cancer. Screening. 2017; https://ec.europa.eu/
health/sites/health/files/major_chronic_diseases/docs/2017_
cancerscreening_2ndreportimplementation_en.pdf.
4. IARC. Breast cancer screening. IARC Hanbooks of Cancer prevention. Lyon:
IARC Press; 2002.
5. Ferroni E, Camilloni L, Jimenez B, Furnari G, Borgia P, Guasticchi G, et al.
How to increase uptake in oncologic screening: a systematic review of
studies comparing population-based screening programs and spontaneous
access. Prev Med. 2012;55:587–96.
6. Bonfill Cosp X, Marzo Castillejo M, Pladevall Vila M, Marti J, Emparanza JI.
Strategies for increasing the participation of women in community breast
cancer screening. In: Cochrane Database of Systematic Reviews: John Wiley
& Sons, Ltd; 2001. https://doi.org/10.1002/14651858.CD002943.
7. Forbes C, Jepson R, Martin-Hirsch P. Interventions targeted at women to
encourage the uptake of cervical screening. 3rd ed: Cochrane Database of
Systematic Reviews; 2002. http://onlinelibrary.wiley.com/doi/10.1002/
14651858.CD002834/full. Accessed 13 Jun 2017
8. Peto J, Gilham C, Fletcher O, Matthews FE. The cervical cancer epidemic
that screening has prevented in the UK. Lancet. 2004;364:249–56.
9. Quinn M, Babb P, Jones J, Allen E. Effect of screening on incidence of and
mortality from cancer of cervix in England: evaluation based on routinely
collected statistics. BMJ. 1999;318:904.
10. Segnan N, Patnick J, von Karsa L. European guidelines for quality assurance
in colorectal cancer screening and diagnosis. 1st ed. Luxembourg:
Publications Office of the European Union: European Commission; 2010.
11. Smith-Bindman R, Chu PW, Miglioretti DL, Sickles EA, Blanks R, Ballard-
Barbash R, et al. Comparison of screening mammography in the United
States and the United Kingdom. JAMA. 2003;290:2129–37.
12. Adab P, Mcghee SM, Yanova J, Wong CM, Hedley AJ. Effectiveness and
efficiency of opportunistic cervical cancer screening: comparison with
organized screening. Med Care. 2004;42:600–9.
13. Palència L, Espelt A, Rodríguez-Sanz M, Puigpinós R, Pons-Vigués M, Pasarín
MI, et al. Socio-economic inequalities in breast and cervical cancer
screening practices in Europe: influence of the type of screening program.
Int J Epidemiol. 2010;39:757–65.
14. Stirbu I, Kunst A, Mielck A, Mackenbach J. Educational inequalities in utilization of
preventive services among elderly in Europe. In: Tackling Health Inequalities in
Europe: An Integrated Approach; 2007. http://survey.erasmusmc.nl/eurothine.
15. European Council A. Council recommendation of 2 December 2003 on
cancer screening (2003/878/EC). 2003.
16. Anttila A, Ronco G, Clifford G, Bray F, Hakama M, Arbyn M, et al. Cervical
cancer screening programmes and policies in 18 European countries. Br J
Cancer. 2004;91:935–41.
17. Holland W, Stewart S, Masseria C. Policy Brief: Screening in Europe.
European Observatory on Health Systems and Policies: Brussels; 2006. http://
www.euro.who.int/en/about-us/partners/observatory/publications/policy-
briefs-and-summaries/screening-in-europe. Accessed 13 Jun 2017
18. Klabunde C, Bouchard F, Taplin S, Scharpantgen A, Ballard-Barbash R.
Quality Assurance for Screening Mammography: an international
comparison. J Epidemiol Community Health (1979). 2001;55:204–12.
19. Gianino MM, Lenzi J, Muça A, Fantini MP, Siliquini R, Ricciardi W, et al.
Declining amenable mortality: time trend (2000-2013) and geographic area
analysis. Health Serv Res. 2017;52:1908–27.
20. Gianino MM, Lenzi J, Bonaudo M, Fantini MP, Siliquini R, Ricciardi W, et al.
The switch between cataract surgical settings: evidence from a time series
analysis across 20 EU countries. PLoS One. 2018;13:e0192620.
21. Shapiro SS, Francia RS. An approximate analysis of variance test for
normality. J Am Stat Assoc. 1972;67:215–6.
22. Döbrőssy L, Kovács A, Budai A. Inequalities in cervical screening practices in
Europe. Divers Equal Health Care. 2015;12:48–53.
23. von Karsa L, Anttila A, Ronco G, Ponti A, Malila N, Arbyn M, et al. Cancer
screening in the European Union report on the implementation of the
council recommendation on cancer screening - first report. Luxembourg:
Services of the European Commission: European Commission; 2008.
24. Miles A, Cockburn J, Smith RA, Wardle J. A perspective from countries using
organized screening programs. Cancer. 2004;101(5 Suppl):1201–13.
25. Hakama M, Chamberlain J, Day NE, Miller AB, Prorok PC. Evaluation of
screening programmes for gynaecological cancer. Br J Cancer. 1985;52:669–73.
26. Spadea T, Bellini S, Kunst A, Stirbu I, Costa G. The impact of interventions to
improve attendance in female cancer screening among lower
socioeconomic groups: a review. Prev Med. 2010;50:159–64.
27. Flannelly GM, Mooney MT, Greehy GM, Keogh EB, McNally SA, Fitzpatrick PE.
Establishment of a national cervical screening programme in Ireland,
CervicalCheck: the first 6 years. Eur J Cancer Prev Off J Eur Cancer Prev Organ ECP.
2016.
28. Arbyn M, Fabri V, Temmerman M, Simoens C. Attendance at cervical Cancer
screening and use of diagnostic and therapeutic procedures on the uterine
cervix assessed from individual health insurance data (Belgium, 2002-2006).
PLoS One. 2014;9:e92615.
29. Van Kerrebroeck H, Makar A. Cervical cancer screening in Belgium and
overscreening of adolescents. Eur J Cancer Prev Off J Eur Cancer Prev Organ
ECP. 2016;25:142–8.
30. Altobelli E, Lattanzi A. Breast cancer in European Union: an update of screening
programmes as of march 2014 (review). Int J Oncol. 2014;45:1785–92.
31. Moutel G, Duchange N, Darquy S, de Montgolfier S, Papin-Lefebvre F, Jullian
O, et al. Women’s participation in breast cancer screening in France – an
ethical approach. BMC Med Ethics. 2014;15:64.
32. Ferrat E, Le Breton J, Djassibel M, Veerabudun K, Brixi Z, Attali C, et
al. Understanding barriers to organized breast cancer screening in
France: women’s perceptions, attitudes, and knowledge. Fam Pract.
2013;30:445–51.
33. Zappa M, Carozzi FM, Giordano L, Sassatelli R, Federerici A. The diffusion of
screening programmes in Italy, years 2011-2012. Epidemiol Prev. 2015;39:5–8.
34. Damiani G, Federico B, Basso D, Ronconi A, Bianchi CBNA, Anzellotti
GM, et al. Socioeconomic disparities in the uptake of breast and
cervical cancer screening in Italy: a cross sectional study. BMC Public
Health. 2012;12:99.
35. McNoe B, Richardson AK, Elwood JM. Factors affecting participation in
mammography screening. N Z Med J. 1996;109:359–61.
36. Rimer BK, Keintz MK, Kessler HB, Engstrom PF, Rosan JR. Why women resist
screening mammography: patient-related barriers. Radiology. 1989;172:243–6.
37. Simon MS, Gimotty PA, Coombs J, McBride S, Moncrease A, Burack RC.
Factors affecting participation in a mammography screening program
among members of an urban Detroit health maintenance organization.
Cancer Detect Prev. 1998;22:30–8.
38. Lagerlund M, Maxwell AE, Bastani R, Thurfjell E, Ekbom A, Lambe M.
Sociodemographic predictors of non-attendance at invitational
mammography screening--a population-based register study (Sweden).
Cancer Causes Control CCC. 2002;13:73–82.
39. Donato F, Bollani A, Spiazzi R, Soldo M, Pasquale L, Monarca S, et al.
Factors associated with non-participation of women in a breast
cancer screening programme in a town in northern Italy. J Epidemiol
Community Health. 1991;45:59–64.
40. Aro AR, de Koning HJ, Absetz P, Schreck M. Psychosocial predictors of first
attendance for organised mammography screening. J Med Screen. 1999;6:82–8.
41. Gram IT, Slenker SE. Cancer anxiety and attitudes toward mammography
among screening attenders, nonattenders, and women never invited. Am J
Public Health. 1992;82:249–51.
Gianino et al. BMC Public Health         (2018) 18:1236 Page 12 of 13
42. Kee F, Telford A, Donaghy P, O’Doherty A. Attitude or access: reasons for
not attending mammography in Northern Ireland. Eur J Cancer Prev. 1992;1:
311–5.
43. Schofield PE, Cockburn J, Hill DJ, Reading D. Encouraging attendance at a
screening mammography Programme: determinants of response to
different recruitment strategies. J Med Screen. 1994;1:144–9.
44. Olsson S, Andersson I, Karlberg I, Bjurstam N, Frodis E, Håkansson S.
Implementation of service screening with mammography in Sweden: from
pilot study to nationwide programme. J Med Screen. 2000;7:14–8.
45. Sabatino SA, Lawrence B, Elder R, Mercer SL, Wilson KM, DeVinney B, et al.
Effectiveness of interventions to increase screening for breast, cervical, and
colorectal cancers: nine updated systematic reviews for the guide to
community preventive services. Am J Prev Med. 2012;43:97–118.
46. Olowokure B, Caswell M, Duggal HV. What women want: convenient
appointment times for cervical screening tests. Eur J Cancer Care (Engl).
2006;15:489–92.
47. Elder JP, Ayala GX, Harris S. Theories and intervention approaches to health-
behavior change in primary care. Am J Prev Med. 1999;17:275–84.
48. Waller J, Bartoszek M, Marlow L, Wardle J. Barriers to cervical cancer
screening attendance in England: a population-based survey. J Med Screen.
2009;16:199–204.
49. Victora CG, Vaughan JP, Barros FC, Silva AC, Tomasi E. Explaining trends in
inequities: evidence from Brazilian child health studies. Lancet Lond Engl.
2000;356:1093–8.
50. Galobardes B, Shaw M, Lawlor DA, Lynch JW. Indicators of socioeconomic
position (part 1). J Epidemiol Community Health. 2006;60:7–12.
51. Krieger N, Williams DR, Moss NE. Measuring social class in US public health
research: concepts, methodologies, and guidelines. Annu Rev Public Health.
1997;18:341–78.
Gianino et al. BMC Public Health         (2018) 18:1236 Page 13 of 13
